Cargando…

Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand

BACKGROUND: Primary ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (POML) is the most common subtype of lymphoma involving the eyes in Thailand. We sought to assess the characteristics and treatment outcomes of patients with POML in Thailand. METHODS: We retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Seresirikachorn, Kasem, Norasetthada, Lalita, Ausayakhun, Sakarin, Apivatthakakul, Atitaya, Tangchittam, Sirima, Pruksakorn, Vannakorn, Wudhikarn, Kitsada, Wiwatwongwana, Damrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300677/
https://www.ncbi.nlm.nih.gov/pubmed/30588468
http://dx.doi.org/10.5045/br.2018.53.4.307
_version_ 1783381719681859584
author Seresirikachorn, Kasem
Norasetthada, Lalita
Ausayakhun, Sakarin
Apivatthakakul, Atitaya
Tangchittam, Sirima
Pruksakorn, Vannakorn
Wudhikarn, Kitsada
Wiwatwongwana, Damrong
author_facet Seresirikachorn, Kasem
Norasetthada, Lalita
Ausayakhun, Sakarin
Apivatthakakul, Atitaya
Tangchittam, Sirima
Pruksakorn, Vannakorn
Wudhikarn, Kitsada
Wiwatwongwana, Damrong
author_sort Seresirikachorn, Kasem
collection PubMed
description BACKGROUND: Primary ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (POML) is the most common subtype of lymphoma involving the eyes in Thailand. We sought to assess the characteristics and treatment outcomes of patients with POML in Thailand. METHODS: We retrospectively reviewed patient data and included patients diagnosed with POML between January 2004 and December 2016 at Chiang Mai University Hospital and King Chulalongkorn Memorial Hospital, Thailand. We collected and analyzed patients' clinical characteristics and treatment outcomes. RESULTS: Among 146 patients with lymphoma involving the eyes, 121 (82%) were diagnosed with POML. Sixty-four (52.9%) were women with median age 58 (range, 22–86) years. The most common presenting symptom was orbital mass (71.1%). Common sites of origin were the orbit (46.3%) and lacrimal gland (34.7%). At presentation, 22.3% of patients had bilateral eye involvement. About half of patients had stage I disease (N=59, 56.2%) and 20% had stage IV. Most patients (73.3%) had a low-risk International Prognostic Index. Radiotherapy was the main treatment for patients with limited-stage disease (66.7% in stage I and 56.5% in stage II). The overall response rate was 100% with complete response rates 80%, 77.3%, and 64.7% for stages I, II, and IV, respectively. Five-year progression-free survival (PFS) and overall survival were 66.1% and 94.0%, respectively. For patients with limited-stage disease, radiotherapy significantly improved PFS compared with treatment not involving radiotherapy (5-year PFS 89.9% vs. 37.3%, P=0.01). CONCLUSION: We revealed that POML has good response to treatment, especially radiotherapy, with excellent long-term outcome.
format Online
Article
Text
id pubmed-6300677
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-63006772018-12-26 Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand Seresirikachorn, Kasem Norasetthada, Lalita Ausayakhun, Sakarin Apivatthakakul, Atitaya Tangchittam, Sirima Pruksakorn, Vannakorn Wudhikarn, Kitsada Wiwatwongwana, Damrong Blood Res Original Article BACKGROUND: Primary ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (POML) is the most common subtype of lymphoma involving the eyes in Thailand. We sought to assess the characteristics and treatment outcomes of patients with POML in Thailand. METHODS: We retrospectively reviewed patient data and included patients diagnosed with POML between January 2004 and December 2016 at Chiang Mai University Hospital and King Chulalongkorn Memorial Hospital, Thailand. We collected and analyzed patients' clinical characteristics and treatment outcomes. RESULTS: Among 146 patients with lymphoma involving the eyes, 121 (82%) were diagnosed with POML. Sixty-four (52.9%) were women with median age 58 (range, 22–86) years. The most common presenting symptom was orbital mass (71.1%). Common sites of origin were the orbit (46.3%) and lacrimal gland (34.7%). At presentation, 22.3% of patients had bilateral eye involvement. About half of patients had stage I disease (N=59, 56.2%) and 20% had stage IV. Most patients (73.3%) had a low-risk International Prognostic Index. Radiotherapy was the main treatment for patients with limited-stage disease (66.7% in stage I and 56.5% in stage II). The overall response rate was 100% with complete response rates 80%, 77.3%, and 64.7% for stages I, II, and IV, respectively. Five-year progression-free survival (PFS) and overall survival were 66.1% and 94.0%, respectively. For patients with limited-stage disease, radiotherapy significantly improved PFS compared with treatment not involving radiotherapy (5-year PFS 89.9% vs. 37.3%, P=0.01). CONCLUSION: We revealed that POML has good response to treatment, especially radiotherapy, with excellent long-term outcome. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018-12 2018-12-17 /pmc/articles/PMC6300677/ /pubmed/30588468 http://dx.doi.org/10.5045/br.2018.53.4.307 Text en © 2018 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Seresirikachorn, Kasem
Norasetthada, Lalita
Ausayakhun, Sakarin
Apivatthakakul, Atitaya
Tangchittam, Sirima
Pruksakorn, Vannakorn
Wudhikarn, Kitsada
Wiwatwongwana, Damrong
Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand
title Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand
title_full Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand
title_fullStr Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand
title_full_unstemmed Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand
title_short Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand
title_sort clinical presentation and treatment outcomes of primary ocular adnexal malt lymphoma in thailand
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300677/
https://www.ncbi.nlm.nih.gov/pubmed/30588468
http://dx.doi.org/10.5045/br.2018.53.4.307
work_keys_str_mv AT seresirikachornkasem clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT norasetthadalalita clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT ausayakhunsakarin clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT apivatthakakulatitaya clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT tangchittamsirima clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT pruksakornvannakorn clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT wudhikarnkitsada clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand
AT wiwatwongwanadamrong clinicalpresentationandtreatmentoutcomesofprimaryocularadnexalmaltlymphomainthailand